MedTrace Logo

Effect of a Kefir Beverage on Immunity and Lipid Profile

NCT03312660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2018-03-05

No results posted yet for this study

Summary

This is an exploratory cluster randomized controlled trial to evaluate the effect of a kefir beverage, enriched with prebiotics components, on immunity, lipid profile and adiposity in a population-based study, using the family as the intervention unit.

Conditions

  • Prebiotics

Interventions

DIETARY_SUPPLEMENT

Prebiotic group

Fermented dairy product with galacto-oligosaccharides (GOS), kefiran and other metabolites resulting from the fermentation with kefir granules.

DIETARY_SUPPLEMENT

Placebo group

Beverage with color, flavor and nutritional composition similar to the fermented dairy product but not containing the prebiotic components.

Sponsors & Collaborators

  • Ministerio de Economía y Competitividad, Spain

    collaborator OTHER_GOV

  • Hospital Clinico Universitario de Santiago

    lead OTHER

Principal Investigators

  • Mar Calvo-Malvar, PhD · Clinic University Hospital of Santiago, Santiago de Compostela, Spain.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2017-11-23
Completion
2017-11-27

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03312660 on ClinicalTrials.gov